Entod Pharmaceuticals Launches Project AXIOM to Explore Novel Myopia Therapy
Entod Pharmaceuticals has launched Project AXIOM, an India-led research programme exploring retinal dopaminergic modulation as a potential approach to slowing progressive myopia.
Therapeutic Innovations | 27/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy